Navigation Links
CVBT Doses First Patient in its Phase II Clinical Trial for Severe Coronary Heart Disease
Date:11/25/2008

p>

CVBT-141H contains and active ingredient -- human Fibroblast Growth Factor-1 (FGF-1). FGF-1 is a natural human protein that stimulates angiogenesis in the affected tissue or organ. Angiogenesis refers to the growth of new blood vessels that may help those suffering from coronary heart disease by increasing blood flow to ischemic tissue or tissue that has been damaged from lack of oxygen and nutrients from blood supply. By providing blood flow to the damaged regions of the heart, the tissues can regenerate.

About Coronary Heart Disease

According to the American Heart Association's 2007 Update, among adults age 20 and older, an estimated 15.8 million Americans (2004) suffer from coronary heart disease (CHD). CHD is the single largest killer of Americans. According such Update, the estimated direct and indirect cost of CHD in the United States for 2007 is $151.6 billion.

About CardioVascular BioTherapeutics, Inc.

CVBT (OTCBB: CVBT) is a biopharmaceutical company developing human FGF-1 for cardiovascular diseases characterized by inadequate blood flow to a tissue or organ. In addition to the Phase II trial it is conducting in patients with severe coronary heart disease, the company is pursuing two FDA-authorized clinical programs in the areas of impaired wound healing seen in diabetes and in patients suffering from peripheral artery disease of the legs. Clinical research is being conducted in patients with chronic back pain who may have perfusion defects to their spine. For more information about CardioVascular BioTherapeutics, Inc. please visit http://www.cvbt.com.

This news release contains forward-looking statements that involve risks and uncertainties. Actual results and outcomes may differ materially from those discussed or anticipated. For example, statements regarding attaining maximum funding levels of clinical d
'/>"/>

SOURCE CardioVascular BioTherapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Trius Doses First Patient in Antibacterial Phase 2 Trial
2. Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
3. Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008-2009 Season in the US
4. Video: Resveratrol-based Nutriceutical (Longevinex(R)) Induces Favorable Changes on Gene Expression in Mouse Heart At Doses 17-320 Times Lower Than Prior Studies
5. Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
6. Sanofi Pasteur to Donate 60 Million Doses of H5N1 Vaccine to WHO Over 3 Years for its Influenza Vaccine Global Stockpile
7. NuRx Pharmaceuticals Doses First Patient in Phase I Clinical Trial of First-in-Class RXR Agonist NRX4204
8. Emisphere Announces Second Study Demonstrating Dramatic Increases in Absorption of Oral B12 Using eligen(R) Technology at Lower Doses
9. Takeda Doses First Patient in a U.S. Phase 1 Study of Hematide(TM) to Treat Chemotherapy Induced Anemia
10. QRxPharma Doses First Patients in Phase III Clinical Trial Program for its Dual Opioid Pain Therapy
11. Peregrine Pharmaceuticals Doses First Patient in Clinical Trial of Bavituximab in HCV Patients Co-Infected With HIV
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... , May 5, 2015  Image Stream Medical, ... new agreement with MedAssets, one of the largest group ... the United States.  Under terms of the three-year agreement, ... and services will be made available to MedAssets members ... the partnership, Image Stream Medical CEO Eddie Mitchell ...
(Date:5/5/2015)... 05, 2015 Research and Markets ... the "Clinical Laboratory,Molecular Diagnostics and Genomic Testing ... - Asia Pacific Version" report to their ... on growing. Clinical laboratory testing is positioned to ... genomics. A range of dynamic trends are pushing ...
(Date:5/5/2015)... are coming up with brilliant ways to help cannabis business solve problems and capitalize on opportunities. However not every idea makes ... ... ... ... Photo - http://photos.prnewswire.com/prnh/20150504/213635-INFO ...
Breaking Medicine Technology:Image Stream Medical Announces Agreement with MedAssets 2Asia Pacific Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market Report 2015-2019 2Top Ten Ways Cannabis Startups are Getting Funded 2Top Ten Ways Cannabis Startups are Getting Funded 3Top Ten Ways Cannabis Startups are Getting Funded 4
... and National HIV/AIDS Elimination Act, NEW YORK, Oct. ... of,advancing prophetic social justice ministry, Black clergy are stepping,forward ... theologically,sound HIV/AIDS public policy. Working with the National Black ... up to the biblical,mandate that calls us to be ...
... Patient Subgroup Will Assess Safety and Anti-Viral ... ... Peregrine,Pharmaceuticals, Inc. (Nasdaq: PPHM ), a clinical stage biopharmaceutical,company ... infection (HCV), today announced that the first patient,has been dosed in ...
Cached Medicine Technology:Statement From The National Conclave on HIV/AIDS Policy for Black Clergy 2Statement From The National Conclave on HIV/AIDS Policy for Black Clergy 3Peregrine Pharmaceuticals Doses First Patient in Clinical Trial of Bavituximab in HCV Patients Co-Infected With HIV 2Peregrine Pharmaceuticals Doses First Patient in Clinical Trial of Bavituximab in HCV Patients Co-Infected With HIV 3Peregrine Pharmaceuticals Doses First Patient in Clinical Trial of Bavituximab in HCV Patients Co-Infected With HIV 4
(Date:5/5/2015)... May 05, 2015 NCPDP announced today ... Program. The program establishes a three-year commitment of strategic ... of 10 Elite Partners. “AmerisourceBergen has supported our multi-stakeholder ... of NCPDP, “and this is a wonderful continuation and ... We can trace AmerisourceBergen back to our very first ...
(Date:5/5/2015)... May 05, 2015 Hiliary Critchley, ... will present at the 24th Annual WEDI ... p.m. MT in Scottsdale, AZ. WEDI, the Workgroup ... nonprofit authority on the use of health IT ... Graf, National Director of Telemedicine for UnitedHealthcare will ...
(Date:5/5/2015)... Viverae®, a health management and ... leading multinational developer, manufacturer and marketer of innovative, ... urology, oncology and surgical specialty products, as the ... Vanguard Award recognizes outstanding achievement in the design ... significant client base. , Viverae reviewed the employee ...
(Date:5/5/2015)... 05, 2015 Nutritional science and medical ... a variety of health conditions and illnesses linked to ... to adopt clean eating methods to rid the body ... with over-consumption of fast and processed foods. Patients find ... to follow and report feeling better and losing excess ...
(Date:5/5/2015)... 2015 MAP Health Management, LLC, a ... management for addiction treatment facilities, announced today that Jimmy ... Business Development. Mr. Mooney, who has more than 35 ... be responsible for developing new strategic partnerships with substance ... products and new initiatives. , Prior to joining MAP, ...
Breaking Medicine News(10 mins):Health News:AmerisourceBergen Joins NCPDP Elite Partner Program 2Health News:AmerisourceBergen Joins NCPDP Elite Partner Program 3Health News:Optimity Advisors’ Hiliary Critchley, Telemedicine Expert, to Speak at WEDI Conference May 20th in Scottsdale, AZ 2Health News:Viverae® Honors C. R. Bard, Inc. with 2015 Vanguard Award 2Health News:Diet Doc Introduces Diet Plans that Teach Patients how to Eat Clean by Getting Back to Basics and Exchanging Processed Foods for Clean, Nutritious Foods 2Health News:Diet Doc Introduces Diet Plans that Teach Patients how to Eat Clean by Getting Back to Basics and Exchanging Processed Foods for Clean, Nutritious Foods 3Health News:Jimmy Mooney, an Addiction Treatment Veteran, Named Vice President of Business Development at MAP Health Management, LLC 2
... , Jan. 15 The March of Dimes has ... mothers and babies in Haiti imperiled by the devastating ... concerned about the thousands of pregnant women and moms caring for ... Dr. Jennifer L. Howse , president of the March of ...
... , Jan. 15 The devastating, 7.0 magnitude earthquake ... situation, particularly for those Haitians living with diabetes. Furthermore, donors ... of the population, such as those victims already living with ... the largest online diabetes community, aims to mobilize its members ...
... ... , ... 15, 2009 -- The United Nations Foundation ,s senior global health expert, Dr. Daniel ... has already met with United Nations staff and will continue to assess the situation on ...
... , , ... wake of this week,s devastating earthquake, premier travel insurance comparison ... LLC ( HCCMIS ) have launched a special initiative providing ... heading to Haiti to aid in relief efforts. ...
... of Dimes Concerned About Drugs, Role in Growing Crisis of Prematurity ... The widespread use of so-called fertility drugs, ... previously realized in the growing problem of premature births in ... of multiple births, the March of Dimes said today. , The ...
... WASHINGTON , Jan. 15 Today the National ... System as the recipient of the 2010 NQF National Quality ... patient-centered healthcare. The award – the first presented to a ... presented in partnership with Modern Healthcare on ...
Cached Medicine News:Health News:March of Dimes Supports Urgent Needs of Mothers and Babies in Haiti Earthquake 2Health News:dLife Connects Largest Online Diabetes Community to Facilitate Aid to Haitian Earthquake Victims Suffering From Diabetes 2Health News:Update from Haiti: United Nations Foundation Vice President for Global Health Delivers Medical Supplies in Port-au-Prince 2Health News:Update from Haiti: United Nations Foundation Vice President for Global Health Delivers Medical Supplies in Port-au-Prince 3Health News:InsureMyTrip.com and HCC Medical Insurance Services Join Forces to Protect Haiti-Bound Relief Workers 2Health News:InsureMyTrip.com and HCC Medical Insurance Services Join Forces to Protect Haiti-Bound Relief Workers 3Health News:InsureMyTrip.com and HCC Medical Insurance Services Join Forces to Protect Haiti-Bound Relief Workers 4Health News:Fertility Drugs Contribute Heavily to Multiple Births 2Health News:Fertility Drugs Contribute Heavily to Multiple Births 3Health News:North Shore-LIJ Health System Receives 2010 NQF National Quality Healthcare Award 2Health News:North Shore-LIJ Health System Receives 2010 NQF National Quality Healthcare Award 3Health News:North Shore-LIJ Health System Receives 2010 NQF National Quality Healthcare Award 4
... an immunoradiometric assay designed,for the ... serum. It is,intended strictly for ... of,two contexts:, (a) serial measurements ... patients with,nonseminomatous testicular cancer and,other ...
Enzyme immunoassay for the quantitative determination of ovarian cancer antigen CA125 in human serum...
Test for prostatic acid phosphatase...
... iMRI is a neurosurgical OR that ... diagnostic tools, including iMRI, necessary to ... iMRI, neurosurgical treatments are performed in ... designed for MR compatibility and safety, ...
Medicine Products: